Recovery-promoting effects of boxing therapy in people with depression receiving inpatient psychiatric care

INTERVENTION: Group 1: The study is planned as a single‐centre, prospective, randomised, controlled trial in the clinical psychiatric setting of Hannover Medical School. The following assessment tools will be used to collect data on the relevant study parameters: Assessment of depressive symptoms Rater assessment: Montgomery Asberg Depression Scale (MADRS) Self assessment: Beck Depression Inventory Revision (BDI‐II) Assessment of participation Inde Xfor Measuring Limitations in Participation (IMET) Empowerment & Resilience Questionnaire for Empowerment and Resilience (STARC‐5) Stress Coping Self‐efficacy Perceived Stress Questionnaire (PSQ) General Self‐Efficacy Scale (SWE) Health‐related quality of life Patient Health Questionnaire (PHQ9) The assessment tools are made available to participants in either digital or analogue form, depending on their individual preference. The data is analysed digitally using appropriate software. Questionnaires completed in analogue form can be posted anonymously into the ‘patient satisfaction survey’ boxes located on the ward. No personal data is collected in either the analogue or digital surveys, meaning that it is impossible to identify any individual. The survey period is intended to last for a total of 10 weeks. The T0 survey will be conducted before the start of the interventions, followed by monitoring of progress after two weeks (T1), four weeks (T2) and si X weeks (T3). A survey four weeks (T4) after the end of the sports therapy programme is planned to mark the end of the study. As part of the study, three weekly practical sessions of contact‐free boxing therapy will be conducted with the participants during their hospi CONDITION: ; F32.2 Severe depressive episode without psychotic symptoms PRIMARY OUTCOME: The primary outcome measure is defined as the reduction in depressive symptoms, ; which is operationalised via the response rate (proportion of ‘responders’) on the ; Montgomery‐Asberg Depression Rating Scale (MADRS). Patients are classified as ; ‘responders’ if their MADRS score improves by 50% over the study period (change ; from baseline to 6 weeks after randomisation). SECONDARY OUTCOME: The effects of the intervention on participation, empowerment and resilience, stress management, self‐efficacy expectations and health‐related quality of life in people ; with depression are considered as secondary endpoints. Potential confounding and covariates for the study objectives include the influence on study participants and reservations about the study. To minimise the influence of these factors on the study objective, transparent communication and the principle of voluntary participation are emphasised. INCLUSION CRITERIA: voluntary or elective in‐patient patients at the Department of Psychiatry, Social Psychiatry and Psychotherapy at Hannover Medical School with a primary diagnosis of depression, for whom there are no medical contraindications to sports therapy measures